Concepedia

Nikoletta L. Kallinteris

NL

Statistics

Publications

12

Citations

379

H-Index

11

Active since

2003

Affiliations

Antigen Express (United States)(Current)

Wayne State University

Harper University Hospital

The Barbara Ann Karmanos Cancer Institute

St Savas Hospital

Nikoletta L. Kallinteris is an author at Antigen Express (United States) specializing in life sciences, immunology, and tumor immunology.

Publications per year

2003–2018

12

Publications

12

Results from a Phase I Clinical Study of the Novel Ii-Key/HER-2/<i>neu</i>(776–790) Hybrid Peptide Vaccine in Patients with Prostate Cancer

Sonia A. Perez, Nikoletta L. Kallinteris, Stratos Bisias et al. · Clinical Cancer Research · 2010 · 65 citations

, , +17

Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors

Nectaria N. Sotiriadou, Nikoletta L. Kallinteris, Angelos D. Gritzapis et al. · Cancer Immunology Immunotherapy · 2006 · 52 citations · Full text

, , +17

Ii-Key/HER-2/ neu MHC class-II antigenic epitope vaccine peptide for breast cancer

Michael E. Gillogly, Nikoletta L. Kallinteris, Minzhen Xu et al. · Cancer Immunology Immunotherapy · 2004 · 47 citations · Full text

, , +12

Induction of potent CD4<sup>+</sup> T cell‐mediated antitumor responses by a helper HER‐2/<i>neu</i> peptide linked to the Ii‐Key moiety of the invariant chain

Ioannis F. Voutsas, Angelos D. Gritzapis, Louisa G. Mahaira et al. · International Journal of Cancer · 2007 · 47 citations

, , +17

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

David E. Gerber, Leora Horn, Michael Boyer et al. · Annals of Oncology · 2018 · 43 citations · Full text

, , +16

1–5 of 12